Literature DB >> 21077716

Antibiotic cycling versus mixing: the difficulty of using mathematical models to definitively quantify their relative merits.

Robert E Beardmore1, Rafael Pena-Miller.   

Abstract

We ask the question Which antibiotic deployment protocols select best against drug-resistant microbes: mixing or periodic cycling? and demonstrate that the statistical distribution of the performances of both sets of protocols, mixing and periodic cycling, must have overlapping supports. In other words, it is a general, mathematical result that there must be mixing policies that outperform cycling policies and vice versa. As a result, we agree with the tenet of Bonhoefer et al. [1] that one should not apply the results of [2] to conclude that an antibiotic cycling policy that implements cycles of drug restriction and prioritisation on an ad-hoc basis can select against drug-resistant microbial pathogens in a clinical setting any better than random drug use. However, nor should we conclude that a random, per-patient drug-assignment protocol is the de facto optimal method for allocating antibiotics to patients in any general sense.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21077716     DOI: 10.3934/mbe.2010.7.923

Source DB:  PubMed          Journal:  Math Biosci Eng        ISSN: 1547-1063            Impact factor:   2.080


  17 in total

1.  Multidrug therapy and evolution of antibiotic resistance: when order matters.

Authors:  Gabriel G Perron; Sergey Kryazhimskiy; Daniel P Rice; Angus Buckling
Journal:  Appl Environ Microbiol       Date:  2012-06-22       Impact factor: 4.792

2.  Alternating antibiotic treatments constrain evolutionary paths to multidrug resistance.

Authors:  Seungsoo Kim; Tami D Lieberman; Roy Kishony
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-22       Impact factor: 11.205

3.  Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America.

Authors:  Tamar F Barlam; Sara E Cosgrove; Lilian M Abbo; Conan MacDougall; Audrey N Schuetz; Edward J Septimus; Arjun Srinivasan; Timothy H Dellit; Yngve T Falck-Ytter; Neil O Fishman; Cindy W Hamilton; Timothy C Jenkins; Pamela A Lipsett; Preeti N Malani; Larissa S May; Gregory J Moran; Melinda M Neuhauser; Jason G Newland; Christopher A Ohl; Matthew H Samore; Susan K Seo; Kavita K Trivedi
Journal:  Clin Infect Dis       Date:  2016-04-13       Impact factor: 9.079

4.  Designing antibiotic cycling strategies by determining and understanding local adaptive landscapes.

Authors:  Christiane P Goulart; Mentar Mahmudi; Kristina A Crona; Stephen D Jacobs; Marcelo Kallmann; Barry G Hall; Devin C Greene; Miriam Barlow
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

5.  Informed switching strongly decreases the prevalence of antibiotic resistance in hospital wards.

Authors:  Roger D Kouyos; Pia Abel Zur Wiesch; Sebastian Bonhoeffer
Journal:  PLoS Comput Biol       Date:  2011-03-03       Impact factor: 4.475

6.  The ecology of antibiotic use in the ICU: homogeneous prescribing of cefepime but not tazocin selects for antibiotic resistant infection.

Authors:  Andrew N Ginn; Agnieszka M Wiklendt; Heather F Gidding; Narelle George; James S O'Driscoll; Sally R Partridge; Brian I O'Toole; Rita A Perri; Joan Faoagali; John E Gallagher; Jeffrey Lipman; Jonathan R Iredell
Journal:  PLoS One       Date:  2012-06-25       Impact factor: 3.240

7.  Application of dynamic modelling techniques to the problem of antibacterial use and resistance: a scoping review.

Authors:  D E Ramsay; J Invik; S L Checkley; S P Gow; N D Osgood; C L Waldner
Journal:  Epidemiol Infect       Date:  2018-07-31       Impact factor: 4.434

8.  The effects of antibiotic cycling and mixing on acquisition of antibiotic resistant bacteria in the ICU: A post-hoc individual patient analysis of a prospective cluster-randomized crossover study.

Authors:  Pleun J van Duijn; Walter Verbrugghe; Philippe G Jorens; Fabian Spöhr; Dirk Schedler; Maria Deja; Andreas Rothbart; Djillali Annane; Christine Lawrence; Matjaz Jereb; Katja Seme; Franc Šifrer; Viktorija Tomič; Francisco Estevez; Jandira Carneiro; Stephan Harbarth; Marc J M Bonten
Journal:  PLoS One       Date:  2022-05-03       Impact factor: 3.752

9.  Policy options for deploying anti-malarial drugs in endemic countries: a population genetics approach.

Authors:  Tiago Antao; Ian Hastings
Journal:  Malar J       Date:  2012-12-17       Impact factor: 2.979

10.  Steering Evolution with Sequential Therapy to Prevent the Emergence of Bacterial Antibiotic Resistance.

Authors:  Daniel Nichol; Peter Jeavons; Alexander G Fletcher; Robert A Bonomo; Philip K Maini; Jerome L Paul; Robert A Gatenby; Alexander R A Anderson; Jacob G Scott
Journal:  PLoS Comput Biol       Date:  2015-09-11       Impact factor: 4.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.